Z. I. Malik Et Al. , "CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (D): INTERIM RESULTS FROM COMPASSIONATE-USE PROGRAMME (CUP) AND EARLY-ACCESS PROGRAMME (EAP)," 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , vol.23, Vienna, Austria, pp.306-307, 2012
Malik, Z. I. Et Al. 2012. CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (D): INTERIM RESULTS FROM COMPASSIONATE-USE PROGRAMME (CUP) AND EARLY-ACCESS PROGRAMME (EAP). 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , (Vienna, Austria), 306-307.
Malik, Z. I., Di Lorenzo, G., Basaran, M., Parente, P., de Schultz, W., Gerritsen, W. R., ... Anton Aparicio, L. M.(2012). CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (D): INTERIM RESULTS FROM COMPASSIONATE-USE PROGRAMME (CUP) AND EARLY-ACCESS PROGRAMME (EAP) . 37th Congress of the European-Society-for-Medical-Oncology (ESMO) (pp.306-307). Vienna, Austria
Malik, Z. Et Al. "CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (D): INTERIM RESULTS FROM COMPASSIONATE-USE PROGRAMME (CUP) AND EARLY-ACCESS PROGRAMME (EAP)," 37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Austria, 2012
Malik, Z. I. Et Al. "CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (D): INTERIM RESULTS FROM COMPASSIONATE-USE PROGRAMME (CUP) AND EARLY-ACCESS PROGRAMME (EAP)." 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , Vienna, Austria, pp.306-307, 2012
Malik, Z. I. Et Al. (2012) . "CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (D): INTERIM RESULTS FROM COMPASSIONATE-USE PROGRAMME (CUP) AND EARLY-ACCESS PROGRAMME (EAP)." 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , Vienna, Austria, pp.306-307.
@conferencepaper{conferencepaper, author={Z. I. Malik Et Al. }, title={CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (D): INTERIM RESULTS FROM COMPASSIONATE-USE PROGRAMME (CUP) AND EARLY-ACCESS PROGRAMME (EAP)}, congress name={37th Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Vienna}, country={Austria}, year={2012}, pages={306-307} }